Skip to main content

Table 3 Uni- and multivariable Cox regression analysis for DFS and OS for patients with HR + , HER2-, pT1-3 IDC or ILC

From: Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer

Variable

Univariable analysis

 

Multivariable analysis

 
 

Hazard ratio (95% CI)

p-value

Hazard ratio (95% CI)

p-value

Model for disease-free survival (120 months)

Age (years)

0.99

(0.99–1.00)

0.20

   

pT

 < 0.001

   

1 (reference)

1.00

     

2

1.59

(1.28–1.97)

 < 0.001

   

3

1.66

(1.01–2.72)

0.04

   

pN

 < 0.001

  

0.20

0 (reference)

1.00

  

1.00

  

1

1.30

(1.02_1.65)

0.03

1.20

(0.73–1.97)

0.46

2

2.25

(1.60–3.18)

 < 0.001

1.50

(0.74–3.02)

0.26

3

4.61

(2.96–7.18)

 < 0.001

2.29

(1.03–5.09)

0.04

Histologic tumor type

Ductal (reference)

1.00

  

1.00

  

Lobular

1.19

(0.90–1.59)

0.20

1.77

(1.08–2.90)

0.02

Grading

0.004

   

1 (reference)

1.00

     

2

1.29

(0.88–1.89)

0.19

   

3

1.76

(1.19–2.60)

0.005

   

LVSI

No (reference)

1.00

  

1.00

  

Yes

1.78

(1.39–2.28)

 < 0.001

1.75

(1.12–2.74)

0.01

Ki-67

1.01

(1.00–1.02)

0.02

   

ER Allred score

0.83

(0.78–0.89)

 < 0.001

0.84

(0.78–0.91)

 < 0.001

PR Allred score

0.94

(0.89–1.00)

0.07

   

Model for overall survival (120 months)

Age (years)

1.03

(1.01–1.04)

 < 0.001

1.05

(1.02–1.07)

 < 0.001

pT

  

 < 0.001

   

1 (reference)

1.00

     

2

2.16

(1.58–2.95)

 < 0.001

   

3

1.41

(0.62–3.25)

0.49

   

pN

 < 0.001

   

0 (reference)

1.00

     

1

1.96

(1.36–2.82)

 < 0.001

   

2

4.35

(2.77–6.83)

 < 0.001

   

3

7.42

(4.16–13.25)

 < 0.001

   

Histologic tumor type

Ductal (reference)

1.00

     

Lobular

1.24

(0.81–1.88)

0.32

   

Grading

  

0.014

   

1 (reference)

1.00

     

2

1.68

(0.90–3.16)

0.11

   

3

2.36

(1.24–4.49)

0.009

   

LVSI

No (reference)

1.00

  

1.00

  

Yes

2.34

(1.64–3.34)

 < 0.001

3.62

(1.92–6.82)

 < 0.001

Ki-67

1.02

(1.00–1.04)

0.01

   

ER Allred score

0.81

(0.74–0.88)

 < 0.001

0.80

(0.73–0.89)

 < 0.001

PR Allred score

0.94

(0.85–1.03)

0.19

   
  1. __________________________________________________________________________________________
  2. HR hormone receptor, HER2 human growth factor receptor 2, CI confidence interval, pT pathological tumor status, pN pathological lymph node status, LVSI lymphovascular space invasion, ER estrogen receptor, PR progesteron receptor